Short term effect of SGLT2 inhibitor, Dapagliflozin added on to standard therapy in decompensated heart failure patients with diabetes mellitus.
Short term effect of SGLT2 inhibitor, Dapagliflozin added on to standard therapy in decompensated heart failure patients with diabetes mellitus.
复制标题
SGLT2 抑制剂达格列净 (Dapagliflozin) 在标准治疗的基础上对患有糖尿病的失代偿性心力衰竭患者的短期疗效。
DOI：
--
复制
发表时间：
2017
期刊：
影响因子：
--
通讯作者：
Dapagliflozin added on to standard therapy in decompensated heart failure patients with diabetes mellitus. ESC2017 2017年8月29日 Barcelon
中科院分区：
文献类型：
--
作者：
Masaki Nakagaito;Shuji Joho;Ryuichi Ushijima;Tadakazu Hirai;Koichiro Kinugawa. Short term effect of SGLT2 inhibitor;Dapagliflozin added on to standard therapy in decompensated heart failure patients with diabetes mellitus. ESC2017 2017年8月29日 Barcelon
